43 related articles for article (PubMed ID: 31059077)
21. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.
Zhou Y; Zhao M; Du Y; Liu Y; Zhao G; Ye L; Li Q; Li H; Wang X; Liu X; Guo Y; Liu J; Huang Y
Thorac Cancer; 2019 Jun; 10(6):1419-1430. PubMed ID: 31070305
[TBL] [Abstract][Full Text] [Related]
23. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
Wang Z; Zhao Y; Xu H; Liang F; Zou Q; Wang C; Jiang J; Lin F
J Cell Mol Med; 2020 Oct; 24(19):11445-11456. PubMed ID: 32910558
[TBL] [Abstract][Full Text] [Related]
24. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
25. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
26. Cancer Statistics, 2017.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2017 Jan; 67(1):7-30. PubMed ID: 28055103
[TBL] [Abstract][Full Text] [Related]
27. Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.
Okazaki I; Ishikawa S; Ando W; Sohara Y
Anticancer Res; 2016 Dec; 36(12):6207-6224. PubMed ID: 27919939
[TBL] [Abstract][Full Text] [Related]
28. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
29. Silencing of CtBP1 suppresses the migration in human glioma cells.
Zhao C; Shen Y; Tao X; Xu J; Lu J; Liu C; Xu Z; Tang Q; Tao T; Zhang X
J Mol Histol; 2016 Jun; 47(3):297-304. PubMed ID: 27160109
[TBL] [Abstract][Full Text] [Related]
30. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
[TBL] [Abstract][Full Text] [Related]
31. miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1.
Han Y; Bi Y; Bi H; Diao C; Zhang G; Cheng K; Yang Z
Hum Cell; 2016 Jan; 29(1):30-6. PubMed ID: 26337822
[TBL] [Abstract][Full Text] [Related]
32. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
33. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
34. XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression.
Cui T; Srivastava AK; Han C; Yang L; Zhao R; Zou N; Qu M; Duan W; Zhang X; Wang QE
Oncotarget; 2015 Apr; 6(12):10060-72. PubMed ID: 25871391
[TBL] [Abstract][Full Text] [Related]
35. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG; Niederst MJ; Sequist LV; Engelman JA
Lancet Oncol; 2015 Apr; 16(4):e165-72. PubMed ID: 25846096
[TBL] [Abstract][Full Text] [Related]
36. Global cancer statistics, 2012.
Torre LA; Bray F; Siegel RL; Ferlay J; Lortet-Tieulent J; Jemal A
CA Cancer J Clin; 2015 Mar; 65(2):87-108. PubMed ID: 25651787
[TBL] [Abstract][Full Text] [Related]
37. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.
Moiola CP; De Luca P; Zalazar F; Cotignola J; Rodríguez-Seguí SA; Gardner K; Meiss R; Vallecorsa P; Pignataro O; Mazza O; Vazquez ES; De Siervi A
Clin Cancer Res; 2014 Aug; 20(15):4086-95. PubMed ID: 24842953
[TBL] [Abstract][Full Text] [Related]
38. SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.
Chen S; Li X; Lu D; Xu Y; Mou W; Wang L; Chen Y; Liu Y; Li X; Li LY; Liu L; Stupack D; Reisfeld RA; Xiang R; Li N
Carcinogenesis; 2014 Mar; 35(3):613-23. PubMed ID: 24233838
[TBL] [Abstract][Full Text] [Related]
39. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma.
Zhang XL; Huang CX; Zhang J; Inoue A; Zeng SE; Xiao SJ
Oncol Rep; 2013 Aug; 30(2):809-14. PubMed ID: 23756565
[TBL] [Abstract][Full Text] [Related]
40. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]